Evidence map›Paper›PMID 33145684›Full record

ArticleJournal of general internal medicine2020

Prospective Investigation of Factors Associated with Prescription Opioid Dose Escalation among Patients in Integrated Health Systems.

Benjamin J Morasco, Ning Smith, Steven K Dobscha, Richard A Deyo, Stephanie Hyde, Bobbi Jo Yarborough

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Journal of general internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02791399 (A Patient-Centered Intervention to Improve Opioid Safety), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02791399 nacompletednot on this map

A Patient-Centered Intervention to Improve Opioid Safety

TypeinterventionalSponsorVA Office of Research and DevelopmentRan2016 to 2020Enrolled286ConditionsOpioid Safety, Prescription Opioid Misuse, Chronic PainArmsISOP Intervention with the Nurse Care Manager
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Benjamin J MorascoCenter to Improve Veteran Involvement in Care, VA Portland Health Care System (R&D99), Portland, OR, USA. benjamin.morasco@va.gov.
Ning SmithKaiser Permanente Northwest Center for Health Research, Portland, OR, USA.
Steven K DobschaCenter to Improve Veteran Involvement in Care, VA Portland Health Care System (R&D99), Portland, OR, USA.
Richard A DeyoKaiser Permanente Northwest Center for Health Research, Portland, OR, USA.
Stephanie HydeCenter to Improve Veteran Involvement in Care, VA Portland Health Care System (R&D99), Portland, OR, USA.
Bobbi Jo YarboroughKaiser Permanente Northwest Center for Health Research, Portland, OR, USA.
Kaiser Permanente Center for Health Research · USVA Portland Health Care System · USOregon Health & Science University · US

Funding

Correlates and outcomes of opioid dose escalation among chronic pain patientsR01DA034083 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI MORASCO, BENJAMIN J. · 2013 to 2017
$2.4M
NIDA NIH HHS R01 DA034083NIH HHS R01DA034083
6 · The paper itself

Abstract

backgroundPrior research has identified factors associated with prescription opioid initiation, but little is known about the prevalence or predictors of dose escalation among patients already prescribed long-term opioid therapy (LTOT).

objectiveThis was a 2-year prospective cohort study to examine patient and clinician factors associated with opioid dose escalation.

designA prospective cohort study. Participants were seen at baseline and every 6 months for a total of 2 years.

participantsPatients prescribed a stable dose of LTOT for musculoskeletal pain were recruited from two integrated health systems (Kaiser Permanente and the Department of Veterans Affairs, respectively). MAIN MEASURES: The prescription opioid dose was based on pharmacy records and self-report. Administrative data were gathered on characteristics of the opioid-prescribing clinician and healthcare utilization. Participants completed measures of pain, functioning, and quality of life. KEY

resultsOf enrolled participants (n = 517), 19.5% had an opioid dose increase. In multivariate analyses, patient variables associated with dose escalation were lower opioid dose (hazard ratio [HR] = 0.86, 95% confidence interval [CI] = 0.79-0.94, for every 10-mg increase in baseline dose) and greater pain catastrophizing (HR = 1.03, 95% CI = 1.01-1.05). Other variables associated with dose escalation were as follows: receiving medications from a nurse practitioner primary care provider (HR = 2.10, 95% CI = 1.12-3.96) or specialty physician (HR = 3.18, 95% CI = 1.22-8.34), relative to a physician primary care provider, and having undergone surgery within the past 6 months (HR = 1.80, 95% CI = 1.10-2.94). Other variables, including pain intensity, pain disability, or depression, were not associated with dose escalation.

conclusionsIn this 2-year prospective cohort study, variables associated with opioid dose escalation were lower opioid dose, higher pain catastrophizing, receiving opioids from a medical specialist (rather than primary care clinician) or nurse practitioner, and having recently undergone surgery. Study findings highlight intervention points that may be helpful for reducing the likelihood of future prescription opioid dose escalation.

Indexed as

Chronic PainDelivery of Health Care, IntegratedAnalgesics, OpioidHumansPrescriptionsProspective StudiesQuality of LifeAnalgesics, Opioidchronic paincohort studylong-term opioid therapyprescription opioid dose escalation

Identifiers

PMID33145684
PMCPMC7728960
OpenAlexW3095110161

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.